L. Gilbert Vezina
Children's National Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by L. Gilbert Vezina.
Journal of Clinical Oncology | 1999
Roger J. Packer; Joel W. Goldwein; H. Stacy Nicholson; L. Gilbert Vezina; Jeffrey C. Allen; M. Douglas Ris; Karin M. Muraszko; Lucy B. Rorke; William M. Wara; Bruce H. Cohen; James M. Boyett
PURPOSE Medulloblastoma is the most common malignant brain tumor of childhood. After treatment with surgery and radiation therapy, approximately 60% of children with medulloblastoma are alive and free of progressive disease 5 years after diagnosis, but many have significant neurocognitive sequelae. This study was undertaken to determine the feasibility and efficacy of treating children with nondisseminated medulloblastoma with reduced-dose craniospinal radiotherapy plus adjuvant chemotherapy. PATIENTS AND METHODS Over a 3-year period, 65 children between 3 and 10 years of age with nondisseminated medulloblastoma were treated with postoperative, reduced-dose craniospinal radiation therapy (23.4 Gy) and 55.8 Gy of local radiation therapy. Adjuvant vincristine chemotherapy was administered during radiotherapy, and lomustine, vincristine, and cisplatin chemotherapy was administered during and after radiation. RESULTS Progression-free survival was 86% +/- 4% at 3 years and 79% +/- 7% at 5 years. Sites of relapse for the 14 patients who developed progressive disease included the local tumor site alone in two patients, local tumor site and disseminated disease in nine, and nonprimary sites in three. Brainstem involvement did not adversely affect outcome. Therapy was relatively well tolerated; however, the dose of cisplatin had to be modified in more than 50% of patients before the completion of treatment. One child died of pneumonitis and sepsis during treatment. CONCLUSION These overall survival rates compare favorably to those obtained in studies using full-dose radiation therapy alone or radiation therapy plus chemotherapy. The results suggest that reduced-dose craniospinal radiation therapy and adjuvant chemotherapy during and after radiation is a feasible approach for children with nondisseminated medulloblastoma.
Epilepsia | 2009
William D. Gaillard; Catherine Chiron; J. Helen Cross; A. Simon Harvey; Ruben Kuzniecky; Lucie Hertz-Pannier; L. Gilbert Vezina
The International League Against Epilepsy (ILAE) Subcommittee for Pediatric Neuroimaging examined the usefulness of, and indications for, neuroimaging in the evaluation of children with newly diagnosed epilepsy. The retrospective and prospective published series with n ≥30 utilizing computed tomography (CT) and magnetic resonance imaging (MRI) (1.5 T) that evaluated children with new‐onset seizure(s) were reviewed. Nearly 50% of individual imaging studies in children with localization‐related new‐onset seizure(s) were reported to be abnormal; 15–20% of imaging studies provided useful information on etiology or and seizure focus, and 2–4% provided information that potentially altered immediate medical management. A significant imaging abnormality in the absence of a history of a localization‐related seizure, abnormal neurologic examination, or focal electroencephalography (EEG) is rare. Imaging studies in childhood absence epilepsy, juvenile absence epilepsy, juvenile myoclonic epilepsy, and benign childhood epilepsy with centrotemporal spikes (BECTS) do not identify significant structural abnormalities. Imaging provides important contributions to establishing etiology, providing prognostic information, and directing treatment in children with recently diagnosed epilepsy. Imaging is recommended when localization‐related epilepsy is known or suspected, when the epilepsy classification is in doubt, or when an epilepsy syndrome with remote symptomatic cause is suspected. When available, MRI is preferred to CT because of its superior resolution, versatility, and lack of radiation.
Biological Psychiatry | 2003
K. Michael Gibson; Maneesh Gupta; Phillip L. Pearl; Mendel Tuchman; L. Gilbert Vezina; O. Carter Snead; Leo M. E. Smit; Cornelis Jakobs
We report two adult patients with succinic semialdehyde dehydrogenase deficiency, manifesting as gamma-hydroxybutyric aciduria. For both, the clinical presentation included significant behavioral disturbances and psychosis (hallucinations, disabling anxiety, aggressive behavior, and sleep disorder), leading to multiple therapeutic attempts. Intervention with benzodiazepines appeared most efficacious, resulting in decreased aggression and agitation and improvement in anxiety. A review of 56 published and unpublished studies of SSADH-deficient patients revealed that 42% manifested behavioral disturbances, whereas 13% (predominantly adults) displayed psychotic symptomatology. To explore the potential biochemical basis of these behavioral abnormalities, we studied cerebrospinal fluid derived from 13 patients, which revealed significantly elevated GHB (65- to 230-fold), high free and total GABA (up to threefold), and low glutamine. Although within the control range, homovanillic and 5-hydroxyindoleacetic acids (end products of dopamine and serotonin metabolism, respectively) showed a significant linear correlation with increasing GHB concentration, suggesting enhanced dopamine and serotonin turnover. We conclude that elevated GABA combined with low glutamine suggest disruption of the glial-neuronal glutamine/GABA/glutamate shuttle necessary for replenishment of neuronal neurotransmitters, whereas altered dopamine and serotonin metabolism may be causally linked to the hyperkinetic movement disorders and behavioral disturbances seen in SSADH-deficient patients.
Cancer | 1996
Roger J. Packer; Michael D. Prados; Peter Phillips; H. Stacy Nicholson; James M. Boyett; Joel Goldwein; Lucy B. Rorke; Michael N. Needle; Leslie Sutton; Robert A. Zimmerman; Charles R. Fitz; L. Gilbert Vezina; Erlinda Etcubanas; Joy C. Wallenberg; Gregory Reaman; William Wara
Prognosis for the majority of children with brain stem gliomas is dismal. In previous studies, recombinant beta‐interferon (rβIF) has been shown to be effective for children with recurrent brain stem gliomas and may also act synergistically with radiotherapy (RT).
Pediatric Neurosurgery | 2000
Susanne M. Schmandt; Roger J. Packer; L. Gilbert Vezina; John A. Jane
An 8-year-old boy with neurofibromatosis type 1 (NF1) and a biopsy-proven juvenile pilocytic astrocytoma of the hypothalamic/chiasmatic region was followed with serial MRIs over 4 years. Spontaneous tumor regression was followed by progression and biopsy; 6 months later, the tumor regressed again. This bimodal regression is rare, but highlights the variable natural history of low-grade gliomas in children with NF1 and the difficulty in evaluating response of such tumors to therapy.
Cancer | 1998
Andrea L. Gropman; Roger J. Packer; H. Stacy Nicholson; L. Gilbert Vezina; Regina Jakacki; Russell Geyer; James M. Olson; Peter Phillips; Michael Needle; Emmett H. Broxson; Gregory Reaman; Jonathan Finlay
The diencephalic syndrome (DS), which is manifested by progressive emaciation and failure to thrive in an apparently alert, cheerful infant, usually is due to a low grade hypothalamic glioma. Treatment with aggressive surgery and/or radiotherapy is variably successful in controlling disease and may result in severe neurologic sequelae. Chemotherapy recently has been shown to be effective in patients with low grade gliomas of childhood, but it is used infrequently in those with DS.
Pediatric Radiology | 2011
Jason W. Schroeder; L. Gilbert Vezina
Masses arising in the sella turcica and the suprasellar region are common in children. The type and frequency of the various lesions encountered in childhood differ from the adult presentation. This article reviews the embryology of the pituitary gland and its normal appearance in childhood as well as the imaging and clinical findings of the common and some of the uncommon lesions arising in the sella turcica, the pituitary stalk, the suprasellar cistern and the lower third ventricle in the pediatric population.
Journal of Child Neurology | 2009
Sarah E. Bain; David T. Hsieh; L. Gilbert Vezina; Taeun Chang
Bilateral paramedian thalamic and mesencephalic infarcts are infrequently reported in adults, and to our knowledge, has never been reported in a child. The presumed etiology is an occlusion of the artery of Percheron, an uncommon vascular variation, in which a single common trunk from one of the P1 segments of the posterior cerebral artery provides bilateral irrigation to the paramedian thalami and midbrain. Bilateral paramedian thalamic and mesencephalic infarcts in adults are associated with symptoms of decreased arousal, vertical gaze paresis, mood changes, and memory difficulties. Although some improvement of these symptoms does occur, complete recovery is rare. We present here a full-term male neonate, whose right-hand sided clonic seizures on day-of-life 2 prompted neuroimaging, which revealed bilateral paramedian thalamic and mesencephalic infarcts, suggestive of an occlusion of the artery of Percheron.
Pediatric Radiology | 2003
Seyed A. Emamian; Elizabeth C. Dubovsky; L. Gilbert Vezina; William Carter; Dorothy I. Bulas
BackgroundA lateral scout view of the head is always obtained when performing head computed tomography (CT). It is common knowledge that viewing the lateral scout view may provide additional information. For a variety of reasons, however, a careful review may not be performed routinely.ObjectiveTo illustrate the value of the lateral scout view, we present a series of representative cases.PatientsSix patients with clinically relevant findings on the scout view.ResultsMost of the ancillary findings were in the upper cervical spine/neck, which is typically included on the lateral scout view.ConclusionCareful evaluation of the scout view of the head CT, including the skull and neck, may yield valuable information, which may not be visualized on the axial CT images.
Oncotarget | 2016
Javad Nazarian; Gary Mason; Cheng Ying Ho; Eshini Panditharatna; Madhuri Kambhampati; L. Gilbert Vezina; Roger J. Packer; Eugene I. Hwang
There is no curative treatment for patients with diffuse intrinsic pontine glioma (DIPG). However, with the recent availability of biopsy and autopsy tissue, new data regarding the biologic behavior of this tumor have emerged, allowing greater molecular characterization and leading to investigations which may result in improved therapeutic options. Treatment strategies must address both primary disease sites as well as any metastatic deposits, which may be variably sensitive to a particular approach. In this case report, we present a patient with DIPG treated with irradiation and serial investigational agents. The clinical, pathological and molecular phenotypes of both the progressive primary tumor as well as concomitant metastatic deposits obtained at autopsy are discussed. While some mRNA differences were demonstrated, all analyzed sites of disease shared similar mutational arrangements, suggesting that targeting the mutations of the primary tumor may be effective for all sites of disease.